Barclays’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-21,042
| Closed | -$331K | – | 5356 |
|
|
2022
Q2 | $331K | Sell |
21,042
-1,017
| -5% | -$15.5K | ﹤0.01% | 3132 |
|
|
2022
Q1 | $335K | Sell |
22,059
-94,559
| -81% | -$1.44M | ﹤0.01% | 3139 |
|
|
2021
Q4 | $1.79M | Buy |
116,618
+92,818
| +390% | +$1.22M | ﹤0.01% | 2453 |
|
|
2021
Q3 | $208K | Buy |
23,800
+754
| +3% | +$6.87K | ﹤0.01% | 3605 |
|
|
2021
Q2 | $236K | Sell |
23,046
-23,156
| -50% | -$244K | ﹤0.01% | 3466 |
|
|
2021
Q1 | $552K | Buy |
46,202
+26,578
| +135% | +$301K | ﹤0.01% | 3122 |
|
|
2020
Q4 | $179K | Sell |
19,624
-6,643
| -25% | -$51.4K | ﹤0.01% | 3825 |
|
|
2020
Q3 | $160K | Sell |
26,267
-32,671
| -55% | -$249K | ﹤0.01% | 3991 |
|
|
2020
Q2 | $523K | Buy |
58,938
+16,197
| +38% | +$140K | ﹤0.01% | 3309 |
|
|
2020
Q1 | $311K | Sell |
42,741
-18,971
| -31% | -$141K | ﹤0.01% | 3971 |
|
|
2019
Q4 | $545K | Sell |
61,712
-7,633
| -11% | -$57.1K | ﹤0.01% | 4229 |
|
|
2019
Q3 | $422K | Sell |
69,345
-26,181
| -27% | -$147K | ﹤0.01% | 4382 |
|
|
2019
Q2 | $399K | Sell |
95,526
-53,643
| -36% | -$283K | ﹤0.01% | 4531 |
|
|
2019
Q1 | $939K | Sell |
149,169
-33,631
| -18% | -$236K | ﹤0.01% | 3469 |
|
|
2018
Q4 | $1.19M | Buy |
182,800
+28,423
| +18% | +$217K | ﹤0.01% | 2947 |
|
|
2018
Q3 | $1.28M | Buy |
154,377
+33,045
| +27% | +$251K | ﹤0.01% | 3387 |
|
|
2018
Q2 | $756K | Buy |
121,332
+79,193
| +188% | +$504K | ﹤0.01% | 3556 |
|
|
2018
Q1 | $288K | Buy |
42,139
+23,316
| +124% | +$148K | ﹤0.01% | 4493 |
|
|
2017
Q4 | $124K | Sell |
18,823
-87,733
| -82% | -$536K | ﹤0.01% | 5072 |
|
|
2017
Q3 | $592K | Buy |
106,556
+95,982
| +908% | +$648K | ﹤0.01% | 3451 |
|
|
2017
Q2 | $82K | Sell |
10,574
-21,245
| -67% | -$180K | ﹤0.01% | 5060 |
|
|
2017
Q1 | $286K | Sell |
31,819
-24,784
| -44% | -$258K | ﹤0.01% | 3972 |
|
|
2016
Q4 | $611K | Buy |
56,603
+56,205
| +14,122% | +$749K | ﹤0.01% | 3188 |
|
|
2016
Q3 | $6K | Buy |
+398
| New | +$5.6K | ﹤0.01% | 5963 |
|
|
2016
Q2 | – | Sell |
-82
| Closed | -$1K | – | 6738 |
|
|
2016
Q1 | $1K | Sell |
82
-15,618
| -99% | -$162K | ﹤0.01% | 6038 |
|
|
2015
Q4 | $157K | Buy |
15,700
+15,541
| +9,774% | +$140K | ﹤0.01% | 4101 |
|
|
2015
Q3 | $1K | Sell |
159
-375
| -70% | -$2.9K | ﹤0.01% | 6647 |
|
|
2015
Q2 | $5K | Buy |
+534
| New | +$4.05K | ﹤0.01% | 6485 |
|
|
2014
Q4 | – | Sell |
-51
| Closed | – | – | 7704 |
|
|
2014
Q3 | $0 | Sell |
51
-4,461
| -99% | -$13.9K | ﹤0.01% | 7881 |
|
|
2014
Q2 | $18K | Buy |
4,512
+1,988
| +79% | +$10.5K | ﹤0.01% | 6574 |
|
|
2014
Q1 | $18K | Buy |
2,524
+105
| +4% | +$782 | ﹤0.01% | 6659 |
|
|
2013
Q4 | $17K | Buy |
2,419
+533
| +28% | +$3.55K | ﹤0.01% | 6798 |
|
|
2013
Q3 | $13K | Sell |
1,886
-59
| -3% | -$459 | ﹤0.01% | 6707 |
|
|
2013
Q2 | $17K | Buy |
+1,945
| New | +$12.5K | ﹤0.01% | 6918 |
|
Other funds holding NPTN
Barclays's NPTN Position: Q3 2022 in Review
Barclays sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 21,042 shares — an estimated $331K sold.
Barclays first reported a position in NPTN in Q2 2013 and held it in 34 quarters. The position peaked at $1.79M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Barclays reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Barclays sold 21,042 NEOPHOTONICS CORP shares in Q3 2022, an estimated $331K.
- Barclays first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 34 quarters.
- Barclays's NEOPHOTONICS CORP position peaked at $1.79M in Q4 2021.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.